Skip to content

Study on the Effect of Selenium Supplementation on the Structure and Function of Autoimmune Thyroiditis

Study on the Effect of Selenium Supplementation on the Structure and Function of Autoimmune Thyroiditis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04942769
Enrollment
30
Registered
2021-06-28
Start date
2019-12-20
Completion date
2021-10-30
Last updated
2021-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Selenium

Brief summary

To evaluate the effects of exogenous selenium supplementation on autoimmune thyroiditis.

Detailed description

In patients with autoimmune thyroiditis, investigators compared changes in thyroid function, anti-thyroid peroxidase antibody, anti-thyroglobulin antibody, thyroid magnetic resonance T1-mapping values and metabolic indicatorsfrom baseline to the end of treatment (12 weeks)

Interventions

DRUGSelenium

selenium 100ug ,take it orally twice daily

Sponsors

Beijing Chao Yang Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

patients with Autoimmune thyroiditis

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Men or women between the ages of 18 and 75 * Clinical diagnosis of autoimmune thyroiditis, serum TPOAb and TGAB positive * Thyroid function is normal, and no drugs affecting thyroid function such as Umetole and Serge have been used

Exclusion criteria

* The contraindications indicated in the Chinese instructions of the drug * Hypothyroidism, hyperthyroidism * Liver function impairment * Renal function impairment * Claustrophobia * Mental disorders

Design outcomes

Primary

MeasureTime frameDescription
anti-thyroglobulin antibody changesChanges from baseline and 3 months during follow-upChanges from baseline and 3 months during follow-up
T1-mapping values of Thyroid MRIChanges from baseline and 3 months during follow-upChanges from baseline and 3 months during follow-up

Countries

China

Contacts

Primary ContactJia Liu, MD
liujia0116@126.com861085231710
Backup ContactXiaomeng Sun
beijingxiaosun2010@163.com861085231711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026